Initial Immune Response to New Biomaterials

Initial Immune Response to New Biomaterials - Immune Response to Biomaterials

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42385

Enrollment

Registered

2015-07-23

Start date

2015-09-15

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart valve prosthesis New heart valves

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Male persons • Feeling physically healthy, defined as not having fever or flu-like symptoms.

Exclusion criteria

Exclusion criteria: • Known infectious / genetic diseases, which could affect the immune system

Design outcomes

Primary

Measure	Time frame
The endpoint for the volunteer to participate in the study will be directly after the blood collection is completed. The main study parameters will be: • Cellular Infiltration	—

Secondary

Measure	Time frame
• Cytokine release profile • Gene expression profile	—

Countries

Netherlands

Outcome results